STEALTH BIOTHERAPEUTICS CORP (MITO) Stock Income Statement
NASDAQ:MITO - Nasdaq - US85789A1051 - ADR - Currency: USD
| TTM (2022-3-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 21.09M | 0.00 | |||
| Operating Expenses | 48.30M | 46.30M | 48.67M | 66.92M | 75.28M | |||
| Research and Development | 28.23M | 26.56M | 29.31M | 44.60M | 53.06M | |||
| Selling, General, and Administrative Expenses | 20.07M | 19.75M | 19.37M | 22.32M | 22.22M | |||
| Operating Income | -48.30M | -46.30M | -48.67M | -45.83M | -75.28M | |||
| Interest Income/Expense | -4.59M | -6.14M | -8.79M | -2.90M | -21.85M | |||
| Non Recurring Items | N/A | -86.00K | 0.00 | -23.00M | 410.00K | |||
| Income Before Taxes | -52.97M | -52.53M | -57.46M | -71.73M | -96.71M | |||
| Net Income | -52.97M | -52.53M | -57.46M | -71.73M | -96.71M | |||
| EBITDA | N/A | -46.23M | -48.44M | -45.55M | -74.97M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.74 | -0.75 | -1.00 | -1.69 | -2.28 | |||
| Non GAAP EPS | -0.08 | -0.08 | -0.11 | -0.15 | N/A | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | -340.11% | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | -217.31% | N/A | |||
All data in USD